| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2981199 | The Journal of Thoracic and Cardiovascular Surgery | 2013 | 9 Pages |
Abstract
Survival after esophagectomy for intramucosal adenocarcinoma is excellent, determined more by patient than cancer characteristics. Patient selection and respiratory function are crucial to minimize harm. Considering the outcome of emerging therapies, esophagectomy should be reserved for patients with a long intramucosal adenocarcinoma or those in whom endoscopic therapies fail or are inappropriate.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Zhigang MD, PhD, Thomas W. MD, Xiuli MD, PhD, John R. MD, Sarah J. MS, Lisa A. MS, Sudish C. MD, PhD, David P. MD, Daniel P. MD, Eugene H. MD,